Contact
Please use this form to send email to PR contact of this press release:
Teva and Checkpoint Therapeutics Announce License Agreement for Oral PARP Inhibitor
TO:
Please use this form to send email to PR contact of this press release:
Teva and Checkpoint Therapeutics Announce License Agreement for Oral PARP Inhibitor
TO: